Combined effects of aging and type 2 diabetes on wound healing in a humanized mouse model
衰老和 2 型糖尿病对人源化小鼠模型伤口愈合的综合影响
基本信息
- 批准号:10266842
- 负责人:
- 金额:$ 20.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgeAgingAmputationAnimal ModelAortaArginineArterial Fatty StreakAtherosclerosisBasic ScienceBecaplerminBiological AvailabilityBiological Response Modifier TherapyCD34 geneCardiovascular DiseasesCellsCessation of lifeChronicClinical ResearchDevelopmentDiabetes MellitusDiabetic Foot UlcerDiseaseElderlyEngraftmentFDA approvedFailureFoot UlcerGastrocnemius MuscleGene ExpressionGoalsHematopoietic stem cellsHumanImmuneImmune systemImpaired wound healingImpairmentInflammatoryMalignant NeoplasmsModelingMusNatural ImmunityNitric OxideNon-Insulin-Dependent Diabetes MellitusOralOxidative StressPathogenesisPatientsPersonsPhasePhenotypePopulationPublishingReportingResearchResearch PersonnelRiskRisk FactorsRodentScientistSupplementationTestingTranslational ResearchType 2 diabeticWorkWound modelsage effectagedascorbatebasecardiovascular risk factorcell agechronic ulcerchronic woundclinically relevantdiabeticdiabetic patientdiabetic ulcerhematopoietic stem cell differentiationhuman diseasehumanized mousehypercholesterolemiaimmune functionimprovedinsightlifetime riskmacrophagemonocytemortalitymouse modelnon-healing woundsnovelnovel therapeutic interventionoxidant stressresearch and developmentrisk sharingstem cell therapytargeted treatmenttetrahydrobiopterintherapeutic evaluationtherapy developmenttoolwoundwound healingwound treatment
项目摘要
Abstract
Aging is a powerful risk factor for the development of chronic, non-healing foot ulcers in people with type 2
diabetes (T2DM). Diabetic foot ulcers in older adults with T2DM have devastating consequences, leading to
increased risks of amputation and all-cause mortality. There is a compelling, unmet need to develop therapies
to treat these non-healing wounds in this population; however, an appropriate animal model for use in the
development of biotherapeutics and stem cell therapies with a high degree of translatability to human disease
does not exist. Therefore, the overall goal of this proposal is to develop an aged-T2DM humanized mouse
model to study the mechanisms by which the combined effects of aging and T2DM dysregulate the human
immune system of T2DM patients during wound healing and to test therapeutics based on these new insights.
To achieve this goal, two Specific Aims are proposed. The purpose of Specific Aim 1 is to develop a humanized
mouse model engrafted with CD34+ hematopoietic stem cells (HSCs) from aged-T2DM human donors to study
wound healing. The hypothesis is that humanized mice engrafted with CD34+ HSCs from older adults with
diabetes faithfully recapitulate the non-healing wound phenotype and skewed polarization of wound-
infiltrating macrophages that has been documented in human T2DM patients. This model is based on our
published and unpublished findings that T2DM and aging impair wound healing by an oxidant stress-
dependent HSC autonomous mechanism. Thus, the aging-T2DM-associated impairment in wound healing will
be conferred by the donor HSCs from aged-T2DM patients. The purpose of Specific Aim 2 is to determine the
effect of ATLAS therapy on wound healing in humanized mice engrafted with aged-T2DM HSCs. The
hypothesis is that ATLAS treatment of HSCs derived from aged T2DM human donors prior to engraftment into
NSG-SGM3 mice reduces HSC oxidant stress and increases nitric oxide bioavailability that restores normal
macrophage number and polarization in wounds. Our results show that in a T2DM murine model of wound
healing ATLAS, a combination of L-arginine, tetrahydrobiopterin, and L-ascorbate, decreases HSC oxidative
stress and increases HSC NO bioavailability that restores normal wound healing. The development of the
proposed humanized mouse model bridges a major gap between murine wound healing models and human
non-healing foot ulcers in older adults with T2DM; thus, the creation of a highly translatable tool to develop
novel biological therapies to treat non-healing wounds in older adults with T2DM fulfills a major unmet need
for these patients. As a consequence of the results of this project, we hope to greatly reduce the suffering from
this devasting problem that disproportionately affects older adults worldwide.
抽象的
衰老是 2 型患者出现慢性、不愈合足部溃疡的一个重要危险因素
糖尿病(T2DM)。患有 T2DM 的老年人的糖尿病足溃疡具有毁灭性的后果,导致
截肢和全因死亡的风险增加。开发治疗方法的需求迫切但尚未得到满足
治疗该人群中这些无法愈合的伤口;然而,合适的动物模型可用于
开发对人类疾病具有高度可转化性的生物疗法和干细胞疗法
不存在。因此,本提案的总体目标是开发老年T2DM人源化小鼠
模型来研究衰老和 T2DM 的综合影响使人类失调的机制
T2DM 患者在伤口愈合过程中的免疫系统,并根据这些新见解测试治疗方法。
为了实现这一目标,提出了两个具体目标。具体目标 1 的目的是开发人性化的
移植了来自老年 T2DM 人类捐赠者的 CD34+ 造血干细胞 (HSC) 的小鼠模型用于研究
伤口愈合。该假设是,人源化小鼠被移植了来自患有老年痴呆症的老年人的 CD34+ HSCs。
糖尿病忠实地再现了不愈合的伤口表型和伤口的偏向极化
已在人类 T2DM 患者中记录到浸润性巨噬细胞。这个模型是基于我们的
已发表和未发表的研究结果表明,T2DM 和衰老会通过氧化应激损害伤口愈合
依赖HSC自主机制。因此,衰老-T2DM 相关的伤口愈合损伤将
由老年 T2DM 患者的供体 HSC 赋予。具体目标 2 的目的是确定
ATLAS 疗法对移植老年 T2DM HSC 的人源化小鼠伤口愈合的影响。这
假设是 ATLAS 对来自老年 T2DM 人类供体的 HSC 进行处理,然后将其植入
NSG-SGM3 小鼠减少 HSC 氧化应激并增加一氧化氮生物利用度,从而恢复正常
伤口中的巨噬细胞数量和极化。我们的结果表明,在 T2DM 小鼠伤口模型中
愈合 ATLAS 是 L-精氨酸、四氢生物蝶呤和 L-抗坏血酸的组合,可降低 HSC 氧化
压力并增加 HSC NO 生物利用度,恢复正常伤口愈合。的发展
提出的人源化小鼠模型弥补了小鼠伤口愈合模型与人类伤口愈合模型之间的主要差距
患有 T2DM 的老年人的不愈合足部溃疡;因此,创建一个高度可翻译的工具来开发
治疗患有 T2DM 的老年人不愈合伤口的新型生物疗法满足了一个重大的未满足需求
对于这些患者。由于该项目的成果,我们希望大大减少以下疾病的痛苦:
这一毁灭性问题对全世界老年人造成了不成比例的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louis Michael Messina其他文献
Louis Michael Messina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Louis Michael Messina', 18)}}的其他基金
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization
高胆固醇血症损害干细胞介导的缺血后新血管形成
- 批准号:
9084611 - 财政年份:2014
- 资助金额:
$ 20.94万 - 项目类别:
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization
高胆固醇血症损害干细胞介导的缺血后新血管形成
- 批准号:
8764380 - 财政年份:2014
- 资助金额:
$ 20.94万 - 项目类别:
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization
高胆固醇血症损害干细胞介导的缺血后新血管形成
- 批准号:
8890880 - 财政年份:2014
- 资助金额:
$ 20.94万 - 项目类别:
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA
ENOS 在严重肢体缺血中的过度表达
- 批准号:
6711255 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice
间充质干细胞治疗糖尿病小鼠后肢缺血
- 批准号:
8463583 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA
ENOS 在严重肢体缺血中的过度表达
- 批准号:
7417446 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA
ENOS 在严重肢体缺血中的过度表达
- 批准号:
7179321 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice
间充质干细胞治疗糖尿病小鼠后肢缺血
- 批准号:
7987780 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA
ENOS 在严重肢体缺血中的过度表达
- 批准号:
6837663 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA
ENOS 在严重肢体缺血中的过度表达
- 批准号:
7058205 - 财政年份:2004
- 资助金额:
$ 20.94万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 20.94万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 20.94万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 20.94万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 20.94万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 20.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 20.94万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 20.94万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 20.94万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 20.94万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 20.94万 - 项目类别:
Miscellaneous Programs